相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cloning and soluble expression of mature α-luffin from Luffa cylindrica and its antitumor activities in vitro
Liling Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Immunotherapy of Malignant Disease with Tumor Antigen-Specific Monoclonal Antibodies
Michael Campoli et al.
CLINICAL CANCER RESEARCH (2010)
Pichia pastoris as a host for secretion of toxic saporin chimeras
Alessio Lombardi et al.
FASEB JOURNAL (2010)
Epidermal growth factor receptor expression affects the efficacy of the combined application of saponin and a targeted toxin on human cervical carcinoma cells
Diana Bachran et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Folding-competent and Folding-defective Forms of Ricin A Chain Have Different Fates after Retrotranslocation from the Endoplasmic Reticulum
Shuyu Li et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases
Daniel A. Vallera et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Draft genome sequence of the oilseed species Ricinus communis
Agnes P. Chan et al.
NATURE BIOTECHNOLOGY (2010)
Differential expression of saporin genes upon wounding, ABA treatment and leaf development
Andrea Tartarini et al.
PHYSIOLOGIA PLANTARUM (2010)
Engineering a switchable toxin: the potential use of PDZ domains in the expression, targeting and activation of modified saporin variants
Francesco Giansanti et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Population-level variation of the preproricin gene contradicts expectation of neutral equilibrium for generalist plant defense toxins
Andrea Weeks et al.
TOXICON (2010)
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Mauro Ferrari
TRENDS IN BIOTECHNOLOGY (2010)
Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication
Praveena S. Marconescu et al.
VACCINE (2010)
The rGel/BLyS Fusion Toxin Inhibits Diffuse Large B-cell Lymphoma Growth In Vitro and In Vivo
Mi-Ae Lyu et al.
NEOPLASIA (2010)
Transition State Analogues Rescue Ribosomes from Saporin-L1 Ribosome Inactivating Protein
Matthew B. Sturm et al.
BIOCHEMISTRY (2009)
Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies
Robert J. Kreitman
BIODRUGS (2009)
Construction and Characterization of Novel, Recombinant Immunotoxins Targeting the Her2/neu Oncogene Product: In vitro and In vivo Studies
Yu Cao et al.
CANCER RESEARCH (2009)
Saponins as Tool for Improved Targeted Tumor Therapies
H. Fuchs et al.
CURRENT DRUG TARGETS (2009)
Current Constructs and Targets in Clinical Development for Antibody-Based Cancer Therapy
P. M. Deckert
CURRENT DRUG TARGETS (2009)
Ricin A Chain Insertion into Endoplasmic Reticulum Membranes Is Triggered by a Temperature Increase to 37 °C
Peter U. Mayerhofer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin
Jeannick Cizeau et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Inhibition of Tumor Growth by Targeted Toxins in Mice is Dramatically Improved by Saponinum Album in a Synergistic Way
Christopher Bachran et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Structure/function studies on two type 1 ribosome inactivating proteins: Bouganin and lychnin
Simona Fermani et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck
G. C. MacDonald et al.
MEDICAL ONCOLOGY (2009)
A Novel Strategy for the Invasive Toxin: Hijacking Exosome-Mediated Intercellular Trafficking
Fan Zhang et al.
TRAFFIC (2009)
Use of antibodies and immunoconjugates for the therapy of more accessible cancers
Robert M. Sharkey et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
In silico docking of urokinase plasminogen activator and integrins
Bernard Degryse et al.
BMC BIOINFORMATICS (2008)
Killing cancer cells by targeted drug-carrying phage nanomedicines
Hagit Bar et al.
BMC BIOTECHNOLOGY (2008)
Antibody-drug conjugates for cancer therapy
Paul J. Carter et al.
CANCER JOURNAL (2008)
Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein
A. Weng et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Targeted therapy of cancer using diphtheria toxin-derived immunotoxins
Sirisha Potala et al.
DRUG DISCOVERY TODAY (2008)
Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer
Morten G. Rasch et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
The role of CDC48 in the retro-translocation of non-ubiquitinated toxin substrates in plant cells
Richard S. Marshall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The catalytic subunit of Shiga-like toxin 1 interacts with ribosomal stalk proteins and is inhibited by their conserved C-terminal domain
Andrew J. McCluskey et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
LDL receptor-related protein 1: Unique tissue-specific functions revealed by selective gene knockout studies
Anna P. Lillis et al.
PHYSIOLOGICAL REVIEWS (2008)
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
Masanori Onda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cytosolic chaperones influence the fate of a toxin dislocated from the endoplasmic reticulum
Robert A. Spooner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Endoplasmic reticulum quality control and the unfolded protein response: Insights from plants
Alessandro Vitale et al.
TRAFFIC (2008)
Phase I study of SS1P a recombinant anti-mesothelin immunotoxin given as a bolus IV infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2007)
Lipopolyamine treatment increases the efficacy of intoxication with saporin and an anticancer saporin conjugate
Sandra E. Geden et al.
FEBS JOURNAL (2007)
Evidence for the importance of electrostatics in the function of two distinct families of ribosome inactivating toxins
Alexei V. Korennykh et al.
RNA (2007)
Saporin as a novel suicide gene in anticancer gene therapy (vol 14, pg 165, 2007)
N. Zarovni et al.
CANCER GENE THERAPY (2007)
Syntaxin 16 and syntaxin 5 are required for efficient retrograde transport of several exogenous and endogenous cargo proteins
Mohamed Amessou et al.
JOURNAL OF CELL SCIENCE (2007)
The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells
Ramadevi Nimmanapalli et al.
BLOOD (2007)
Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells
Wai Lam Yip et al.
MOLECULAR PHARMACEUTICS (2007)
A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice
Hendrik Fuchs et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Overexpression of biologically active VEGF121 fusion proteins in Escherichia coli
Sehoon Kim et al.
JOURNAL OF BIOTECHNOLOGY (2007)
Saporin as a novel suicide gene in anticancer gene therapy
N. Zarovni et al.
CANCER GENE THERAPY (2007)
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA
Mi-Ae Lyu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice
Edward Rustamzadeh et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Immunotoxin treatment of cancer
Ira Pastan et al.
ANNUAL REVIEW OF MEDICINE (2007)
Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients
Masanori Onda et al.
JOURNAL OF IMMUNOLOGY (2006)
Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway
Sang-Wook Kang et al.
CELL (2006)
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
Leonard G. Presta
ADVANCED DRUG DELIVERY REVIEWS (2006)
Ribosome-inactivating proteins: progress and problems
F. Stirpe et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13
Edward Rustamzadeh et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
The urokinase receptor: a ligand or a receptor? Story of a sociable molecule
P. Ragno
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
A pilot clinical trial of a recombinant ricin vaccine in normal humans
ES Vitetta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates
CD Austin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ricin poisoning - A comprehensive review
J Audi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells
R Vago et al.
FEBS JOURNAL (2005)
A novel neutralizing monoclonal antibody against cell-binding polypeptide of ricin
JW Guo et al.
HYBRIDOMA (2005)
Delivery into cells: lessons learned from plant and bacterial toxins
K Sandvig et al.
GENE THERAPY (2005)
Quantitative immunoassay of biotoxins on hydrogel-based protein microchips
AY Rubina et al.
ANALYTICAL BIOCHEMISTRY (2005)
Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody
T Piazza et al.
JOURNAL OF CELL SCIENCE (2005)
Forensic identification of neat ricin and of ricin from crude castor bean extracts by mass spectrometry
SA Fredriksson et al.
ANALYTICAL CHEMISTRY (2005)
The 1.4Å structure of dianthin 30 indicates a role of surface potential at the active site of type 1 ribosome inactivating proteins
S Fermani et al.
JOURNAL OF STRUCTURAL BIOLOGY (2005)
Penetratin improves tumor retention of single-chain antibodies: A novel step toward optimization of radioimmunotherapy of solid tumors
M Jain et al.
CANCER RESEARCH (2005)
Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor
L Qi et al.
CANCER RESEARCH (2004)
A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model
DA Todhunter et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Vascular targeting agents as cancer therapeutics
PE Thorpe
CLINICAL CANCER RESEARCH (2004)
Cytotoxic ribosome-inactivating lectins from plants
MR Hartley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
The type-1 and type-2 ribosome-inactivating proteins from Iris confer transgenic tobacco plants local but not systemic protection against viruses
F Vandenbussche et al.
PLANTA (2004)
Isolation and characterization of an RIP (ribosome-inactivating protein)-like protein from tobacco with dual enzymatic activity
N Sharma et al.
PLANT PHYSIOLOGY (2004)
Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum
RA Spooner et al.
BIOCHEMICAL JOURNAL (2004)
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase
G Bellisola et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Pegylation: Engineering improved biopharmaceuticals for oncology
G Molineux
PHARMACOTHERAPY (2003)
Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice
JE Smallshaw et al.
NATURE BIOTECHNOLOGY (2003)
The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities
S Bagga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells
JG Ramage et al.
LEUKEMIA RESEARCH (2003)
Pharmacokinetics and biodistribution of genetically engineered antibodies
SK Batra et al.
CURRENT OPINION IN BIOTECHNOLOGY (2002)
Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris
JH Woo et al.
PROTEIN EXPRESSION AND PURIFICATION (2002)
The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol
ED Deeks et al.
BIOCHEMISTRY (2002)
Ricin A chain without its partner B chain is degraded after retrotranslocation from the endoplasmic reticulum to the cytosol in plant cells
A Di Cola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: In vitro results and in vivo effects in an acute rejection model
PL Tazzari et al.
JOURNAL OF IMMUNOLOGY (2001)
Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia
PD Hall et al.
CLINICAL IMMUNOLOGY (2001)
Ribosome-inactivating proteins from plants: more than RNA N-glycosidases?
WJ Peumans et al.
FASEB JOURNAL (2001)
The internal propeptide of the ricin precursor carries a sequence-specific determinant for vacuolar sorting
L Frigerio et al.
PLANT PHYSIOLOGY (2001)
Ribosome-inactivating proteins: A plant perspective
K Nielsen et al.
ANNUAL REVIEW OF PLANT PHYSIOLOGY AND PLANT MOLECULAR BIOLOGY (2001)
Polynucleotide:adenosine glycosidase is the sole activity of ribosome-inactivating proteins on DNA
L Barbieri et al.
JOURNAL OF BIOCHEMISTRY (2000)
The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro:: Insights into toxin-mediated vascular damage
R Baluna et al.
EXPERIMENTAL CELL RESEARCH (2000)
Trichosanthin interacts with and enters cells via LDL receptor family members
WL Chan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Engineering of a mini-trichosanthin that has lower antigenicity by deleting its C-terminal amino acid residues
SH Chan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Recombinant toxins that bind to the urokinase receptor are cytotoxic without requiring binding to the α2-macroglobulin receptor
V Rajagopal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Phase I trial of recombinant immunotoxin anti-Tac(Fv)PE38 (LMB-2) in patients with hematologic malignancies
RJ Kreitman et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Molecular cloning of a cDNA encoding ribosome inactivating protein from Amaranthus viridis and its expression in E-coli
SY Kwon et al.
MOLECULES AND CELLS (2000)
Modeling and alanine scanning mutagenesis studies of recombinant pokeweed antiviral protein
F Rajamohan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome
C Savino et al.
FEBS LETTERS (2000)
Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells
MS Fabbrini et al.
FASEB JOURNAL (2000)
Expression of biologically active recombinant pokeweed antiviral protein in methylotrophic yeast Pichia pastoris
F Rajamohan et al.
PROTEIN EXPRESSION AND PURIFICATION (2000)
Heterologous protein expression in the methylotrophic yeast Pichia pastoris
JL Cereghino et al.
FEMS MICROBIOLOGY REVIEWS (2000)
A novel mechanism for inhibition of translation by pokeweed antiviral protein: Depurination of the capped RNA template
KA Hudak et al.
RNA (2000)
分享论文
